Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5613)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Park JG, Park SY, Lee HW. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy. World J Gastroenterol 2015; 21(8): 2568-2572 [PMID: 25741170 DOI: 10.3748/wjg.v21.i8.2568] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i8/2568.htm |
| Number | Citing Articles |
| 1 |
Jie Mao, Hongbao Yang, Tingting Cui, Pan Pan, Nadia Kabir, Duo Chen, Jinyan Ma, Xingyi Chen, Yijun Chen, Yong Yang. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT. European Journal of Pharmacology 2018; 832: 39 doi: 10.1016/j.ejphar.2018.05.027
|
| 2 |
Ken Liu, Geoffrey W. McCaughan. How to select the appropriate “neoadjuvant therapy” for hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2018; 19(11): 1167 doi: 10.1080/14656566.2018.1498843
|
| 3 |
Chen Shuanggang, Lujun Shen, Zhiyu Qiu, Han Qi, Fei Cao, Lin Xie, Weijun Fan. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2020; 16(2): 250 doi: 10.4103/jcrt.JCRT_345_19
|
| 4 |
Peng-Hui Hu, Lan-Hong Pan, Patrick Ting-Yat Wong, Wen-Hui Chen, Yan-Qing Yang, Hong Wang, Jun-Jian Xiang, Meng Xu. <sup>125</sup>I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(21): 5033-5041 doi: 10.3748/wjg.v22.i21.5033
|
| 5 |
Joseph W. Franses, Andrew X. Zhu. Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present. Clinical Cancer Research 2022; 28(13): 2738 doi: 10.1158/1078-0432.CCR-22-0025
|
| 6 |
Chengxu Sui, Chengjun Zhuang, Deguang Sun, Li Yang, Liang Zhang, Lei Song. Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma. Oncotarget 2017; 8(28): 45837 doi: 10.18632/oncotarget.17434
|
| 7 |
Shusei Sano, Shinji Nakata, Shuichi Wada, Masatsugu Kuroiwa, Hiroki Sakai, Kei Kusama, Taiichi Machida, Akihito Nishio, Ichiro Ito, Harutsugu Sodeyama. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1772-8
|